Atria Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Atria Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Buy	39,602 +6,650	+20%	+$221K	0.01%	961
2026 Q1	$993K	Buy	32,952 +13,932	+73%	+$448K	0.01%	1057
2025 Q4	$594K	Buy	+19,020	New	+$469K	0.01%	1334
2025 Q2	–	Sell	-21,055	Closed	-$324K	–	2075
2025 Q1	$324K	Sell	21,055 -2,898	-12%	-$51.8K	﹤0.01%	1579
2024 Q4	$528K	Sell	23,953 -6,903	-22%	-$126K	0.01%	1297
2024 Q3	$556K	Buy	30,856 +17,746	+135%	+$311K	0.01%	1265
2024 Q2	$213K	Buy	+13,110	New	+$202K	﹤0.01%	1788

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Atria Investments's TEVA Position: Q2 2026 in Review

Atria Investments increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 20% in Q2 2026, buying an estimated $221K and bringing the position to 39,602 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #961.

Atria Investments first reported a position in TEVA in Q2 2024 and has held it in 7 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Atria Investments held 39,602 shares of Teva Pharmaceutical Industries Limited worth $1.34M as of Q2 2026.
Atria Investments bought 6,650 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $221K.
Teva Pharmaceutical Industries Limited made up 0.01% of Atria Investments's portfolio in Q2 2026, its #961 holding.
Atria Investments first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 7 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.